Cutler Group’s Gyre Therapeutics GYRE Stock Holding History

Cutler Group’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-367	Closed	-$2K	–	3888
2023 Q3	$2K	Hold	367	–	–	﹤0.01%	3262
2023 Q2	$1K	Hold	367	–	–	﹤0.01%	3288
2023 Q1	$1K	Sell	367 -366	-50%	-$1.39K	﹤0.01%	3436
2022 Q4	$2K	Hold	733	–	–	﹤0.01%	3694
2022 Q3	$2K	Hold	733	–	–	﹤0.01%	4202
2022 Q2	$9K	Hold	733	–	–	﹤0.01%	3269
2022 Q1	$3K	Hold	733	–	–	﹤0.01%	4457
2021 Q4	$5K	Hold	733	–	–	﹤0.01%	4182
2021 Q3	$22K	Hold	733	–	–	﹤0.01%	3264
2021 Q2	$23K	Hold	733	–	–	﹤0.01%	3183
2021 Q1	$27K	Hold	733	–	–	﹤0.01%	2936
2020 Q4	$34K	Hold	733	–	–	﹤0.01%	2273
2020 Q3	$23K	Hold	733	–	–	﹤0.01%	2349
2020 Q2	$32K	Hold	733	–	–	﹤0.01%	2056
2020 Q1	$24K	Hold	733	–	–	﹤0.01%	2176
2019 Q4	$37K	Sell	733 -296	-29%	-$12.4K	﹤0.01%	1831
2019 Q3	$37K	Hold	1,029	–	–	﹤0.01%	1750
2019 Q2	$56K	Buy	1,029 +922	+862%	+$57.6K	0.01%	1467
2019 Q1	$6K	Hold	107	–	–	﹤0.01%	2792
2018 Q4	$6K	Sell	107 -3,773	-97%	-$278K	﹤0.01%	2831
2018 Q3	$313K	Buy	3,880 +2,680	+223%	+$212K	0.02%	642
2018 Q2	$105K	Buy	1,200 +1,040	+650%	+$182K	0.01%	1123
2018 Q1	$30K	Buy	+160	New	+$29.8K	﹤0.01%	2007
2017 Q3	–	Sell	-120	Closed	-$4K	–	6166
2017 Q2	$4K	Buy	+120	New	+$4.31K	﹤0.01%	5015
2016 Q1	–	Sell	-39	Closed	-$13K	–	6745
2015 Q4	$13K	Buy	+39	New	+$15.3K	﹤0.01%	3848

Other funds holding GYRE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cutler Group's GYRE Position: Q4 2023 in Review

Cutler Group sold out of Gyre Therapeutics (GYRE) in Q4 2023, closing a stake of 367 shares — an estimated $2K sold.

Cutler Group first reported a position in GYRE in Q4 2015 and held it in 25 quarters. The position peaked at $313K in Q3 2018. 16 funds tracked by Wall St. Rank hold GYRE as of Q4 2023.

Cutler Group reported no remaining Gyre Therapeutics position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 367 Gyre Therapeutics shares in Q4 2023, an estimated $2K.
Cutler Group first reported a position in Gyre Therapeutics in Q4 2015 and held it in 25 quarters.
Cutler Group's Gyre Therapeutics position peaked at $313K in Q3 2018.
16 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.